Baxter International Inc. (BAX): Price and Financial Metrics
BAX Price/Volume Stats
| Current price | $42.14 | 52-week high | $73.63 |
| Prev. close | $40.96 | 52-week low | $37.35 |
| Day low | $40.94 | Volume | 4,682,200 |
| Day high | $42.22 | Avg. volume | 6,150,157 |
| 50-day MA | $43.06 | Dividend yield | 2.81% |
| 200-day MA | $48.32 | Market Cap | 21.32B |
BAX Stock Price Chart Interactive Chart >
BAX POWR Grades
- Sentiment is the dimension where BAX ranks best; there it ranks ahead of 92.25% of US stocks.
- The strongest trend for BAX is in Value, which has been heading up over the past 179 days.
- BAX's current lowest rank is in the Quality metric (where it is better than 38.04% of US stocks).
BAX Stock Summary
- BAX has a higher market value than 90.47% of US stocks; more precisely, its current market capitalization is $21,306,405,454.
- BAX's went public 37.42 years ago, making it older than 93.61% of listed US stocks we're tracking.
- Over the past twelve months, BAX has reported earnings growth of -235.06%, putting it ahead of merely 7.11% of US stocks in our set.
- Stocks that are quantitatively similar to BAX, based on their financial statements, market capitalization, and price volatility, are ZBH, TEVA, XRAY, HAS, and IFF.
- BAX's SEC filings can be seen here. And to visit BAXTER INTERNATIONAL INC's official web site, go to www.baxter.com.
BAX Valuation Summary
- BAX's price/earnings ratio is -8.7; this is 136.1% lower than that of the median Healthcare stock.
- Over the past 243 months, BAX's EV/EBIT ratio has gone down 35.
Below are key valuation metrics over time for BAX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| BAX | 2023-05-23 | 1.4 | 3.7 | -8.7 | -18.7 |
| BAX | 2023-05-22 | 1.4 | 3.7 | -8.8 | -18.7 |
| BAX | 2023-05-19 | 1.4 | 3.7 | -8.8 | -18.8 |
| BAX | 2023-05-18 | 1.4 | 3.7 | -8.8 | -18.9 |
| BAX | 2023-05-17 | 1.4 | 3.7 | -8.8 | -18.8 |
| BAX | 2023-05-16 | 1.4 | 3.7 | -8.8 | -18.9 |
BAX Growth Metrics
- Its year over year net cashflow from operations growth rate is now at 4.05%.
- Its 5 year revenue growth rate is now at 12.36%.
- The 3 year price growth rate now stands at -7.68%.
The table below shows BAX's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 15,113 | 1,211 | -2,433 |
| 2022-09-30 | 14,740 | 1,465 | -2,376 |
| 2022-06-30 | 14,193 | 1,850 | 1,011 |
| 2022-03-31 | 13,545 | 2,053 | 1,057 |
| 2021-12-31 | 12,784 | 2,222 | 1,284 |
| 2021-09-30 | 12,451 | 2,241 | 1,214 |
BAX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- BAX has a Quality Grade of C, ranking ahead of 64.68% of graded US stocks.
- BAX's asset turnover comes in at 0.631 -- ranking 63rd of 186 Medical Equipment stocks.
- PEN, MDT, and IART are the stocks whose asset turnover ratios are most correlated with BAX.
The table below shows BAX's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.631 | 0.393 | 0.106 |
| 2021-06-30 | 0.616 | 0.391 | 0.102 |
| 2021-03-31 | 0.598 | 0.387 | 0.096 |
| 2020-12-31 | 0.594 | 0.393 | 0.098 |
| 2020-09-30 | 0.600 | 0.407 | 0.069 |
| 2020-06-30 | 0.617 | 0.414 | 0.072 |
BAX Price Target
For more insight on analysts targets of BAX, see our BAX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $94.21 | Average Broker Recommendation | 1.56 (Moderate Buy) |
Baxter International Inc. (BAX) Company Bio
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois. (Source:Wikipedia)
Latest BAX News From Around the Web
Below are the latest news stories about BAXTER INTERNATIONAL INC that investors may wish to consider to help them evaluate BAX as an investment opportunity.
Here's Why We're Wary Of Buying Baxter International's (NYSE:BAX) For Its Upcoming DividendBaxter International Inc. ( NYSE:BAX ) is about to trade ex-dividend in the next 4 days. The ex-dividend date is one... |
Baxter to Present at Jefferies Healthcare ConferenceDEERFIELD, Ill., May 24, 2023--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023. José (Joe) Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:00 a.m. Eastern Time. |
Is Baxter International (BAX) an Attractive Investment?Artisan Partners, an investment management company, released its “Artisan Value Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. In the first quarter, the fund outperformed the Russell 1000 Value Index. Its Investor Class fund ARTLX returned 7.88%, Advisor Class fund APDLX posted a return of 7.93%, and Institutional Class […] |
Artivion Announces FDA PMA Approval of PerClot and Transfer of PMA to BaxterArtivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) granted premarket application (PMA) approval of PERCLOT Absorbable Hemostatic System ("PerClot") for use to control bleeding in certain open and laparoscopic surgical procedures. Artivion sold the PerClot product line to Baxter International Inc. ("Baxter"), (NYSE: BAX), in July 2021. Pursuant to the terms of its previously announ |
Baxter International's (NYSE:BAX) Dividend Will Be $0.29Baxter International Inc. ( NYSE:BAX ) will pay a dividend of $0.29 on the 3rd of July. Based on this payment, the... |
BAX Price Returns
| 1-mo | -1.48% |
| 3-mo | 11.63% |
| 6-mo | -18.40% |
| 1-year | -40.72% |
| 3-year | -50.02% |
| 5-year | -39.39% |
| YTD | -16.14% |
| 2022 | -39.58% |
| 2021 | 8.48% |
| 2020 | -2.95% |
| 2019 | 28.40% |
| 2018 | 2.89% |
BAX Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching BAX
Want to see what other sources are saying about Baxter International Inc's financials and stock price? Try the links below:Baxter International Inc (BAX) Stock Price | Nasdaq
Baxter International Inc (BAX) Stock Quote, History and News - Yahoo Finance
Baxter International Inc (BAX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...